# Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer

> **NCT05141643** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** PET Scan

## Key facts

- **NCT ID:** NCT05141643
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-18
- **Primary completion:** 2026-11-18
- **Final completion:** 2026-11-18
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141643, "Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05141643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
